Floatz logo

Xeomin®

Subdeltoid Bursitis

Benha UniversityEarly Phase 1Dormant
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Subdeltoid Bursitis cohort.

Asset / SponsorPhaseRating
Methyl Prednisolonate
Benha University
Early Phase 1C
HYALURONATE
Shin Kong Wu Ho-Su Memorial Hospital
N/AD
LIDOCAINE
Shin Kong Wu Ho-Su Memorial Hospital
N/AD

Same molecule, other indications

Xeomin® is also rated in:

Muscle SpasticityDormant
BBB
Indicative ·
79 / 100
View asset →
Migraine DisordersDormant
BBB
Indicative ·
77 / 100
View asset →
stroke disorderDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →